1,280.34
price up icon4.46%   54.61
pre-market  Pre-market:  1274.50   -5.84   -0.46%
loading
Lilly Eli Co stock is traded at $1,280.34, with a volume of 4.43M. It is up +4.46% in the last 24 hours and up +8.59% over the past month. Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
See More
Previous Close:
$1,225.73
Open:
$1245.81
24h Volume:
4.43M
Relative Volume:
1.50
Market Cap:
$1.14T
Revenue:
$72.25B
Net Income/Loss:
$25.28B
P/E Ratio:
46.09
EPS:
27.781
Net Cash Flow:
$10.37B
1W Performance:
+4.92%
1M Performance:
+8.59%
6M Performance:
+25.13%
1Y Performance:
+82.07%
1-Day Range:
Value
$1,240.54
$1,292.65
1-Week Range:
Value
$1,163.50
$1,292.65
52-Week Range:
Value
$685.15
$1,292.65

Lilly Eli Co Stock (LLY) Company Profile

Name
Name
Lilly Eli Co
Name
Phone
(317) 276-2000
Name
Address
LILLY CORPORATE CTR, INDIANAPOLIS, IN
Name
Employee
50,000
Name
Twitter
@LillyPad
Name
Next Earnings Date
2026-08-05
Name
Latest SEC Filings
Name
LLY's Discussions on Twitter

Compare LLY vs JNJ, ABBV, MRK, NVS

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
LLY icon
LLY
Lilly Eli Co
1,280.34 1.09T 72.25B 25.28B 10.37B 27.78
JNJ icon
JNJ
Johnson Johnson
273.41 653.35B 97.93B 21.04B 17.80B 8.6278
ABBV icon
ABBV
Abbvie Inc
265.97 457.54B 62.82B 3.60B 19.98B 2.0274
MRK icon
MRK
Merck Co Inc
152.20 333.49B 65.51B 8.93B 14.12B 3.5532
NVS icon
NVS
Novartis Ag Adr
160.31 293.76B 54.66B 13.58B 16.05B 7.0171

Lilly Eli Co Stock (LLY) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-17-26 Downgrade HSBC Securities Hold → Reduce
Feb-25-26 Initiated RBC Capital Mkts Outperform
Feb-20-26 Initiated Barclays Overweight
Jan-07-26 Resumed UBS Buy
Dec-16-25 Upgrade Daiwa Securities Neutral → Buy
Dec-15-25 Reiterated BofA Securities Buy
Dec-15-25 Reiterated Goldman Buy
Nov-13-25 Initiated Scotiabank Sector Outperform
Nov-10-25 Upgrade Leerink Partners Market Perform → Outperform
Oct-20-25 Reiterated BMO Capital Markets Outperform
Oct-14-25 Upgrade Erste Group Hold → Buy
Sep-17-25 Downgrade Berenberg Buy → Hold
Aug-27-25 Upgrade HSBC Securities Reduce → Hold
Aug-18-25 Downgrade Daiwa Securities Outperform → Neutral
Aug-07-25 Downgrade Leerink Partners Outperform → Market Perform
Jun-05-25 Downgrade Erste Group Buy → Hold
Apr-28-25 Downgrade HSBC Securities Buy → Reduce
Apr-22-25 Initiated Cantor Fitzgerald Overweight
Dec-10-24 Resumed BofA Securities Buy
Nov-15-24 Initiated Wolfe Research Outperform
Oct-17-24 Initiated Bernstein Outperform
Sep-13-24 Resumed Citigroup Buy
Aug-12-24 Upgrade Deutsche Bank Hold → Buy
Feb-21-24 Downgrade DZ Bank Buy → Hold
Feb-16-24 Reiterated Morgan Stanley Overweight
Dec-21-23 Downgrade Daiwa Securities Buy → Outperform
Nov-09-23 Initiated Deutsche Bank Hold
Oct-20-23 Resumed UBS Buy
Aug-09-23 Upgrade Jefferies Hold → Buy
Jul-26-23 Reiterated Citigroup Buy
Jul-14-23 Initiated HSBC Securities Buy
May-24-23 Reiterated BofA Securities Buy
May-24-23 Reiterated UBS Buy
Mar-13-23 Upgrade Wells Fargo Equal Weight → Overweight
Mar-06-23 Initiated Jefferies Hold
Feb-15-23 Downgrade Societe Generale Hold → Sell
Nov-18-22 Initiated Credit Suisse Outperform
Sep-22-22 Upgrade UBS Neutral → Buy
May-23-22 Initiated SVB Leerink Outperform
Apr-06-22 Resumed Morgan Stanley Overweight
Mar-10-22 Initiated Daiwa Securities Outperform
Jan-21-22 Upgrade DZ Bank Hold → Buy
Jan-03-22 Reiterated Bernstein Mkt Perform
Dec-17-21 Initiated Goldman Neutral
Dec-16-21 Reiterated BMO Capital Markets Outperform
Dec-16-21 Reiterated BofA Securities Buy
Dec-09-21 Resumed Wells Fargo Equal Weight
Nov-19-21 Initiated BMO Capital Markets Outperform
Oct-11-21 Upgrade Berenberg Hold → Buy
Sep-29-21 Upgrade Citigroup Neutral → Buy
Aug-05-21 Upgrade DZ Bank Hold → Buy
Jul-27-21 Resumed Truist Buy
Jun-24-21 Reiterated Cantor Fitzgerald Overweight
Jan-19-21 Upgrade Mizuho Neutral → Buy
Dec-10-20 Upgrade Wolfe Research Peer Perform → Outperform
Nov-10-20 Resumed Bernstein Mkt Perform
Sep-29-20 Initiated Berenberg Hold
Sep-03-20 Upgrade Morgan Stanley Equal-Weight → Overweight
Jun-16-20 Upgrade Guggenheim Neutral → Buy
Apr-21-20 Downgrade UBS Buy → Neutral
Apr-09-20 Downgrade Morgan Stanley Overweight → Equal-Weight
Feb-06-20 Initiated Mizuho Neutral
Dec-18-19 Upgrade Morgan Stanley Equal-Weight → Overweight
Oct-17-19 Resumed BofA/Merrill Buy
May-28-19 Initiated Goldman Buy
Apr-24-19 Upgrade Edward Jones Hold → Buy
Apr-11-19 Downgrade Guggenheim Buy → Neutral
Mar-12-19 Initiated JP Morgan Overweight
Jan-23-19 Initiated UBS Buy
Nov-26-18 Downgrade Citigroup Buy → Neutral
Oct-31-18 Upgrade Credit Suisse Underperform → Neutral
Oct-09-18 Initiated Guggenheim Buy
Oct-01-18 Reiterated SunTrust Buy
Sep-26-18 Resumed JP Morgan Overweight
View All

Lilly Eli Co Stock (LLY) Latest News

pulisher
03:14 AM

Eli Lilly and Company $LLY Shares Bought by AlTi Global Inc. - MarketBeat

03:14 AM
pulisher
Aug 19, 2026

Upper Macungie planners endorse Eli Lilly plan for manufacturing campus - wfmz.com

Aug 19, 2026
pulisher
Aug 19, 2026

Eli Lilly Price Forecast: The Next Big Stock After Weight-Loss Drug Breakthrough? - Mitrade

Aug 19, 2026
pulisher
Aug 19, 2026

Can Eli Lilly Catch Novo Nordisk in the Oral GLP-1 Race? - Yahoo Finance

Aug 19, 2026
pulisher
Aug 19, 2026

Eli Lilly and Company (NYSE:LLY) Trading 4.5% HigherHere's Why - MarketBeat

Aug 19, 2026
pulisher
Aug 19, 2026

Eli Lilly and Co (LLY) Stock Up 4.5% and Still Undervalued -- GF Score: 96/100 - GuruFocus

Aug 19, 2026
pulisher
Aug 19, 2026

Could Eli Lilly Be Worth More Than SpaceX by the End of 2026? - Yahoo Finance

Aug 19, 2026
pulisher
Aug 19, 2026

LLY Looks 15.4% Undervalued on GF Value™ Amid New Vaccine Partne - GuruFocus

Aug 19, 2026
pulisher
Aug 19, 2026

Amplitude Therapeutics and Lilly Enter Strategic Collaboration to Develop Trans-Amplifying RNA Vaccines for Infectious Diseases - PR Newswire

Aug 19, 2026
pulisher
Aug 19, 2026

Eli Lilly Shares Approach High as 60% Volume Surge Offsets 13% Price Fall - TechStock²

Aug 19, 2026
pulisher
Aug 19, 2026

Eli Lilly hits $1 trillion valuation, with stro... - Pluang

Aug 19, 2026
pulisher
Aug 19, 2026

Eli Lilly, Novo Nordisk and Merck: Buy, Sell or Hold? - 24/7 Wall St.

Aug 19, 2026
pulisher
Aug 19, 2026

Lilly Stock Rises on Alzheimer Deal: Retatrutide Moat Still Not Fully Priced - Tech Times

Aug 19, 2026
pulisher
Aug 19, 2026

How Does LLY's Q2 GLP-1 Portfolio Performance Stack Up Against NVO's? - TradingView

Aug 19, 2026
pulisher
Aug 19, 2026

Stock Forecast: The Market is Sleeping on Eli Lilly’s Next $1 Trillion Opportunity - 24/7 Wall St.

Aug 19, 2026
pulisher
Aug 19, 2026

Eli Lilly and Company (NYSE:LLY) Reaches New 12-Month HighStill a Buy? - MarketBeat

Aug 19, 2026
pulisher
Aug 19, 2026

Eli Lilly and Co Stock (LLY) Moved Up by 5.18% on Aug 19: What Investors Need To Know - TradingKey

Aug 19, 2026
pulisher
Aug 19, 2026

Eli Lilly (NYSE:LLY): Is Its Valuation Story Getting Stronger? - Kalkine Media

Aug 19, 2026
pulisher
Aug 19, 2026

Eli Lilly stock hits all-time high at 1249.95 USD By Investing.com - Investing.com Nigeria

Aug 19, 2026
pulisher
Aug 19, 2026

Why is Eli Lilly stock surging today? - Investing.com

Aug 19, 2026
pulisher
Aug 19, 2026

Lilly Turns Lifelong Struggle with Weight Into Story of Hope in ‘A Life Covered’ - Little Black Book | LBBOnline

Aug 19, 2026
pulisher
Aug 19, 2026

Inside Eli Lilly’s Pre-Launch Push to Police the Retatrutide Market - thefashionlaw.com

Aug 19, 2026
pulisher
Aug 19, 2026

Eli Lilly (NYSE:LLY) Expands Neuroscience Reach With New Drug Deals - Kalkine Media

Aug 19, 2026
pulisher
Aug 19, 2026

Lilly Is Trailing In Obesity Pills; How Long Will That Last? - Investor's Business Daily

Aug 19, 2026
pulisher
Aug 19, 2026

CNBC Final Trades: Netflix, Eli Lilly, Elanco Animal Health & MoreNetflix (NASDAQ:NFLX), Eli Lilly (NY - Benzinga

Aug 19, 2026
pulisher
Aug 19, 2026

OmniAb secures up to $370m Lilly deal for ion channel program - BioXconomy

Aug 19, 2026
pulisher
Aug 19, 2026

Janney Montgomery Scott LLC Has $357.98 Million Stock Position in Eli Lilly and Company $LLY - MarketBeat

Aug 19, 2026
pulisher
Aug 19, 2026

Parr Mcknight Wealth Management Group LLC Acquires 1,702 Shares of Eli Lilly and Company $LLY - MarketBeat

Aug 19, 2026
pulisher
Aug 19, 2026

HighTower Advisors LLC Sells 4,236 Shares of Eli Lilly and Company $LLY - MarketBeat

Aug 19, 2026
pulisher
Aug 19, 2026

Convergence Financial LLC Purchases 4,147 Shares of Eli Lilly and Company $LLY - MarketBeat

Aug 19, 2026
pulisher
Aug 19, 2026

Fifth Third Bancorp Sells 212,702 Shares of Eli Lilly and Company $LLY - MarketBeat

Aug 19, 2026
pulisher
Aug 19, 2026

Eli Lilly and Company $LLY Shares Bought by BLB&B Advisors LLC - MarketBeat

Aug 19, 2026
pulisher
Aug 19, 2026

Novo takes first round of oral obesity duel. Can it stay ahead of Lilly? - BioSpace

Aug 19, 2026
pulisher
Aug 18, 2026

UnitedHealth Group (UNH) vs. Eli Lilly and Company (LLY): Which Healthcare Stock Offers the Better Dividend? - Yahoo Finance

Aug 18, 2026
pulisher
Aug 18, 2026

Eli Lilly (LLY) Adds Neuroscience And Lung Cancer Research Deals - Yahoo Finance

Aug 18, 2026
pulisher
Aug 18, 2026

Eli Lilly (NYSE:LLY): What Could Shift the Healthcare Story? - Kalkine Media

Aug 18, 2026
pulisher
Aug 18, 2026

Eli Lilly and Company (NYSE:LLY) Stock Price Up 3.7%What's Next? - MarketBeat

Aug 18, 2026
pulisher
Aug 18, 2026

Eli Lilly and Company (NYSE:LLY) EVP Sells $7,638,150.00 in Stock - MarketBeat

Aug 18, 2026
pulisher
Aug 18, 2026

Eli Lilly and Co(LLY.US) Officer Sells US$7.64 Million in Common Stock - moomoo.com

Aug 18, 2026
pulisher
Aug 18, 2026

How Lilly, Stock Of The Day, Is Regaining On Its Chief Rival - Investor's Business Daily

Aug 18, 2026
pulisher
Aug 18, 2026

Why Eli Lilly (LLY) Stock Is Up Today - StockStory

Aug 18, 2026
pulisher
Aug 18, 2026

Eli Lilly & Co. stock outperforms competitors on strong trading day - MarketWatch

Aug 18, 2026
pulisher
Aug 18, 2026

Eli Lilly and Co Stock (LLY) Moved Up by 3.19% on Aug 18: What Signal Does It Send? - TradingKey

Aug 18, 2026
pulisher
Aug 18, 2026

Eli Lilly Stock Jumps 2.6% as Investors Flee Expensive Tech - TradingView

Aug 18, 2026
pulisher
Aug 18, 2026

Eli Lilly (LLY) Stock Looks Undervalued Relative To Fair Value - simplywall.st

Aug 18, 2026
pulisher
Aug 18, 2026

Inside Eli Lilly's Global CRM Partnership With Veeva - Healthcare Digital

Aug 18, 2026
pulisher
Aug 18, 2026

OmniAb signs $370 million ion channel discovery deal with Eli Lilly - The Pharma Letter

Aug 18, 2026
pulisher
Aug 18, 2026

M&A Roundup: LEO Pharma Acquires Dersimelagon, BioMarin Acquires Alesta, OmniAb Enters collaboration with Eli Lilly, Chugai and GSK Enter License Agreement for AID351 - Pharmaceutical Executive

Aug 18, 2026
pulisher
Aug 18, 2026

Genentech, two other drug companies object to Lilly's planned buyout of bankrupt Sangamo's tech - The Business Journals

Aug 18, 2026
pulisher
Aug 18, 2026

Leal Therapeutics Closes $30M Series A Extension With Eli Lilly Investment - citybiz

Aug 18, 2026
pulisher
Aug 18, 2026

Why Is Eli Lilly (NYSE:LLY) Drawing Attention after Its Strongest Quarter? - Kalkine Media

Aug 18, 2026

Lilly Eli Co Stock (LLY) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
JNJ JNJ
$273.41
price up icon 0.85%
$265.97
price up icon 2.72%
MRK MRK
$152.20
price up icon 12.60%
NVS NVS
$160.31
price up icon 3.73%
AZN AZN
$164.95
price up icon 3.03%
Cap:     |  Volume (24h):